INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 4,820.00
+140.00 (2.99%)
Oct 2, 2026, 3:30 PM KST
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 48.13 billion as of October 2, 2026. Its market cap has decreased by -59.97% in one year.
Market Cap
48.13B
Enterprise Value
49.84B
Revenue
5.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,820.00
ChartMarket Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 48.13B, a decrease of -77.96%. That is a compound annual growth rate of -8.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 48.13B | -54.05% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 372.29B |
| BAIKSAN Co,. | 207.00B |
| Au Brandz Co.,Ltd | 203.06B |
| Hwaseung Enterprise | 164.80B |
| SYTS Corp. | 136.56B |
| HWASEUNG Industries | 107.34B |
| Nine & Company | 98.20B |
| Uni-Chem | 37.83B |